Drug Profile
RG 7345
Alternative Names: RG7345; RO-6926496Latest Information Update: 31 Mar 2016
Price :
$50
*
At a glance
- Originator Roche
- Class Antidementias; Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 01 Jan 2015 Phase-I clinical trials in Alzheimer's disease (In volunteers) in United Kingdom (IV) (NCT02281786)
- 30 Oct 2014 Preclinical trials in Undefined indication in Switzerland (IV)
- 30 Oct 2014 Roche plans a phase I trial for Healthy volunteers in the UK (NCT02281786)